| 臺大學術典藏 |
2021-11-30T04:53:42Z |
IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis
|
Chou C.-H.; Hung C.-S.; Liao C.-W.; Wei L.-H.; Chen C.-W.; Shun C.-T.; Wen W.-F.; Wan C.-H.; Wu X.-M.; Chang Y.-Y.; VIN-CENT WU; Wu K.-D.; Lin Y.-H. |
| 臺大學術典藏 |
2022-09-08T02:21:50Z |
IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis
|
Chou, Chia-Hung; Hung, Chi-Sheng; Liao, Che-Wei; LING-HUNG WEI; CHING-WAY CHEN; Shun, Chia-Tung; Wen, Wen-Fen; Wan, Cho-Hua; Wu, Xue-Ming; Chang, Yi-Yao; Wu, Vin-Cent; Wu, Kwan-Dun; Lin, Yen-Hung |
| 國立臺灣大學 |
2009 |
IL-6 經由Smad恢復TGF-beta對樹狀細胞成熟的抑制
|
陳墨繁; Chen, Mo-Fan |
| 國立臺灣大學 |
2015 |
IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study
|
Kao, Jung-Ta; Feng, Chun-Lung; Yu, Cheng-Ju; Tsai, Shu-Mei; Hsu, Ping-Ning; Chen, Yao-Li; Wu, Yi-Ying; 許秉寧 |
| 臺大學術典藏 |
2021-02-02T02:47:59Z |
IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: A cohort study
|
Kao J.-T.; Feng C.-L.; Yu C.-J.; Tsai S.-M.; PING-NING HSU; Chen Y.-L.; Wu Y.-Y. |
| 國立臺灣大學 |
2007 |
Il-6-Encoding Tumor Antigen Generates Potent Cancer Immunotherapy through Antigen Processing and Anti-Apoptotic Pathways
|
謝長堯; 陳祈安; 黃家彥; 張明正; 李建南; 蘇怡寧; 鄭文芳; HSIEH, CHANG-YAO; CHEN, CHI-AN; HUANG, CHIA-YEN; CHANG, MING-CHENG; LEE, CHIEN-NAN; SU, YI-NING; CHENG, WEN-FANG |
| 臺大學術典藏 |
2007 |
IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways
|
CHIEN-NAN LEE; WEN-FANG CHENG; CHI-AN CHEN; Hsieh, C.-Y. and Chen, C.-A. and Huang, C.-Y. and Chang, M.-C. and Lee, C.-N. and Su, Y.-N. and Cheng, W.-F. |
| 臺大學術典藏 |
2020-01-22T07:50:45Z |
IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways
|
Cheng W.-F.; Su Y.-N.; Lee C.-N.; Chang M.-C.; Huang C.-Y.; CHI-AN CHEN; Hsieh C.-Y.; Hsieh C.-Y.;Chi-An Chen;Huang C.-Y.;Chang M.-C.;Lee C.-N.;Su Y.-N.;Cheng W.-F. |
| 臺大學術典藏 |
2020-02-06T05:22:23Z |
IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways
|
WEN-FANG CHENG;Su Y.-N.;Lee C.-N.;Chang M.-C.;Huang C.-Y.;Chen C.-A.;Hsieh C.-Y.; Hsieh C.-Y.; Chen C.-A.; Huang C.-Y.; Chang M.-C.; Lee C.-N.; Su Y.-N.; WEN-FANG CHENG; Hsieh C.-Y.; Chen C.-A.; Huang C.-Y.; Chang M.-C.; Lee C.-N.; Su Y.-N.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-12T04:06:10Z |
IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways
|
Cheng W.-F.;Su Y.-N;CHIEN-NAN LEE;Chang M.-C;Huang C.-Y;Chen C.-A;Hsieh C.-Y; Hsieh C.-Y; Chen C.-A; Huang C.-Y; Chang M.-C; CHIEN-NAN LEE; Su Y.-N; Cheng W.-F. |
| 臺大學術典藏 |
2020-02-14T02:50:06Z |
IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways
|
Hsieh C.-Y.;Chen C.-A.;Huang C.-Y.;Chang M.-C.;Lee C.-N.;Su Y.-N.;Wen-Fang Cheng; Hsieh C.-Y.; Chen C.-A.; Huang C.-Y.; Chang M.-C.; Lee C.-N.; Su Y.-N.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-11-27T08:14:25Z |
IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways
|
Chang-Yao Hsieh;Chen C.-A.;Huang C.-Y.;Chang M.-C.;Lee C.-N.;Su Y.-N.;Cheng W.-F.; CHANG-YAO HSIEH; Chen C.-A.; Huang C.-Y.; Chang M.-C.; Lee C.-N.; Su Y.-N.; Cheng W.-F. |
| 臺大學術典藏 |
2021-02-04T06:05:02Z |
IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways
|
Hsieh C.-Y.;Chen C.-A.;Huang C.-Y.;Chang M.-C.;Chien-Nan Lee;Su Y.-N.;Cheng W.-F.; Hsieh C.-Y.; Chen C.-A.; Huang C.-Y.; Chang M.-C.; CHIEN-NAN LEE; Su Y.-N.; Cheng W.-F. |
| 國立臺灣大學 |
2007-10 |
IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways.
|
Hsieh, CY; Chen, CA; Huang, CY; Chang, MC; Lee, CN; Su, YN; Cheng, WF |
| 國家衛生研究院 |
2010-06 |
IL-6-transfected tumor cells modulate the status of CD8+ and CD4+ T cells to control tumor growth
|
Hsieh, CL;Liu, SJ;Shen, CR;Chen, MY;Hsu, SC;Tsai, JP;Li, YS;Yang, CJ;Chong, P;Chen, HW |
| 中國醫藥大學 |
2010-06 |
IL-6-transfected tumor cells modulate the status of CD8+ and CD4+ T cells to control tumor growth
|
謝嘉齡(Chia-Ling Hsieh); 劉士仕(Shih-Jen Liu); 沈家瑞(Chia-Rui Shen); 陳玫瑜(Mei-Yu Chen); 許素菁(Shu-Ching Hsu); 蔡之平(Jy-Ping Tsai); 李宜軒(Yi-Shiuan Li); 楊靜仁(Ching-Jen Yang); 莊再成(Pele Chong); 陳信偉(Hsin-Wei Chen)* |
| 臺北醫學大學 |
2010 |
IL-6刺激人類肺部纖維母細胞結締組織生長因子表現之分子機轉探討
|
蔡睿益 |
| 中國醫藥大學 |
2018-12-04 |
IL-6參與lapatinib引發三陰性乳癌轉移之探討
|
蕭宇君;Yu-Chun Hsiao |
| 國立臺灣大學 |
2016 |
IL-6反式訊息傳遞途徑在放射線導致之肺纖維化中所扮演的角色
|
吳晉睿; Wu, Chin-Jui |
| 元培科技大學 |
2017-11-13 |
IL-6受體抗體在k-ras突變的結腸直腸癌細胞上抑制體內腫瘤生長和血管
|
劉葦君;徐治平;鍾元強 |
| 元培科技大學 |
2020 |
IL-6和VEGF-A信號傳導抑制劑聯合療法對大腸癌細胞的抑制效果
|
葉家銨 |
| 國立成功大學 |
2009-06-26 |
IL-6和惡性胸水肺腺癌臨床及免疫調控相關性
|
李妍蒨; Lee, Yen-Chien |
| 國立成功大學 |
2011-01-24 |
IL-6的分泌與肺癌病人存活時間的相關性與抑制IL-6分泌的方法
|
葉裕民; Yeh, Yu-Min |
| 國立臺灣大學 |
2008-07-31 |
IL-6調控人類基底細胞癌之趨化激素及其受體表現與其對腫瘤生物特性之影響(3/3)
|
紀秀華 |
| 臺大學術典藏 |
2018-09-10T15:17:53Z |
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer
|
Liu, Y.-N. and Chang, T.-H. and Tsai, M.-F. and Wu, S.-G. and Tsai, T.-H. and Chen, H.-Y. and Yu, S.-L. and Yang, J.C.-H. and Shih, J.-Y.; JIN-YUAN SHIH |
